1. Share Talk
  2. Healthcare

Healthcare

26Jun 2017

Advanced Oncotherapy Plc (AIM:AVO) Final Results

Advanced Oncotherapy (AIM: AVO), the developer of next generation proton therapy systems for cancer treatment, announces audited results for the year ended 31 December 2016, another year of significant development of the Company’s LIGHT system.

15Jun 2017

Consort Medical Plc (LSE:CSRT) Full year results

Consort Medical plc (LSE: CSRT) (“Consort”, “Consort Medical” or the “Group”), a leading, global, single source drug and delivery device company, today announces its audited results for the year ended 30 April 2017.

26May 2017

Scientific Digital Imaging plc TRADING UPDATE

SDI LOGO 3

Scientific Digital Imaging plc (“SDI”, the “Company” or the “Group”) (AIM: SDI) 

Trading Update

The Board of Scientific Digital Imaging plc, the AIM quoted group focused on the design and manufacture of scientific and technology products for use by the life science, healthcare, astronomy, consumer manufacturing and art conservation markets, is pleased to announce an update on trading for the 12 month period ended 30 April 2017. 

23May 2017

SkinBioTherapeutics PLC (AIM:SBTX) Extension of research contract with University of Manchester

SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, announces that, as envisaged in the Company’s Admission Document dated 29 March 2017, it has agreed an eight month extension to its research contract with the University of Manchester to June 2018. This contract extension includes provision for the appointment of a second technician to the Company. This will increase the Company’s ability to develop its SkinBiotix® platform.

10May 2017

EKF Diagnostics Hldg Trading Update & Structure Update

EKF Diagnostics

EKF Diagnostics Holdings plc (“EKF”, the “Company”) 

Trading update & Update re: possible demerger and share buyback 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, wishes to update shareholders on its current trading and the proposals it set out in its announcement on 20 March 2017.

3May 2017

N4 Pharma Plc (AIM:N4P) Admission to AIM/Interview with CEO

N4 Pharma Plc (AIM: N4P), a specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance, is pleased to announce the readmission today of the Company’s ordinary shares to trading on AIM and the commencement of dealings in the New Ordinary Shares under the ticker N4P (“Admission”).

Share Talk took the opportunity to speak with N4 Pharma’s Founder and CEO Nigel Theobald following their admission and first day of shares being available for dealing on AIM .

26Apr 2017

ShareTalk spoke to Jerry Randall, Chief Executive Officer of Venture Life Group

Today Share Talk spoke to Jerry Randall, Chief Executive Officer of Venture Life Group. We look at the business in depth from the Board of Directors and the past history of the company’s partners. We look into the products and how they fit into the self care category and how they are in the public domain as a branded set of products. We look at the business model and how they plan to expand their global reach and expand on their product base.

10Apr 2017

These 10 companies control everything you buy

Only 10 companies control almost every large food and beverage brand in the world.

These companies — Nestlé, PepsiCo, Coca-Cola, Unilever, Danone, General Mills, Kellogg’s, Mars, Associated British Foods, and Mondelez — each employ thousands and make billions of dollars in revenue every year.

Page 1 of 212
DON’T MISS OUT!
Subscribe To Our Newsletter
Be the first to get latest updates and exclusive content straight to your email inbox.
Stay Updated
Give it a try, you can unsubscribe anytime.
close-link